Cognitive tests for psychiatry

Impact: Health and wellbeing, Economic


Cognitive biomarkers are of considerable interest in psychiatry and to those developing treatments (pharmacological or psychological). We have developed a set of tests of affective functions which may be of particular relevance to functional outcomes in mental health. 4 tests have been licensed to Cambridge Cognition Ltd. 12 tests are under ongoing review pending further results.
Impact date2016
Category of impactHealth and wellbeing, Economic
Impact levelUndefined